Financial Performance - Net profit attributable to shareholders rose by 25.06% to CNY 23,789,742.43 for the reporting period[7] - Operating revenue for the period reached CNY 93,983,932.83, reflecting a 40.10% increase year-on-year[7] - The net profit attributable to shareholders after deducting non-recurring gains and losses surged by 93.34% to CNY 22,154,309.35 for the reporting period[7] - The company’s net profit increased by 96.92% to ¥138,571,115.95, indicating strong performance growth during the reporting period[16] - The company's net profit attributable to shareholders reached ¥23,789,742.43, an increase from ¥19,022,083.69 in the previous period, reflecting a growth of approximately 25.5%[35] - The net profit for the period was ¥24,519,618.78, compared to ¥14,364,301.97 in the previous period, marking an increase of around 70.8%[38] - The net profit for Q3 2017 was CNY 64,664,712.13, representing an increase of 40.6% compared to CNY 45,990,013.75 in the same period last year[46] Revenue and Sales - Operating revenue rose by 34.06% to ¥242,638,817.36, driven by increased product sales and effective market expansion[16] - Total operating revenue for Q3 2017 reached ¥93,983,932.83, an increase from ¥67,083,909.40 in the previous period[33] - Total revenue from sales of goods and services was CNY 219,117,901.73, compared to CNY 164,074,239.49 in the prior year, reflecting a growth of 33.5%[48] Assets and Liabilities - Total assets increased by 92.39% to CNY 679,733,172.44 compared to the end of the previous year[7] - The total net assets attributable to shareholders increased by 102.44% to CNY 623,338,152.13 compared to the end of the previous year[7] - Total liabilities rose to ¥56,395,020.31, compared to ¥45,394,971.26 in the previous period[30] - The company’s accounts payable increased by 47.95% to ¥11,305,823.94, reflecting growth in business volume and procurement[16] Cash Flow - The net cash flow from operating activities increased by 179.61% to CNY 58,440,118.69 year-to-date[7] - Cash flow from operating activities generated a net amount of CNY 58,440,118.69, significantly higher than CNY 20,900,424.39 in the previous year, marking an increase of 179.5%[49] - The net cash flow from operating activities for Q3 2017 was ¥72,824,294.80, a significant increase from ¥14,364,075.37 in the same period last year, representing a growth of approximately 408%[53] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,639[11] - The largest shareholder, Forward Investment (Hong Kong) Co., Ltd., held 23.58% of the shares[11] Expenses - The company reported a significant increase in sales expenses, which rose to ¥37,362,986.27 from ¥24,181,443.30, an increase of about 54.5%[37] - The total operating costs increased to ¥168,893,326.17 from ¥141,183,437.89, indicating a rise of approximately 19.7%[40] - The company incurred sales expenses of CNY 87,970,765.16, which is an increase of 37.0% from CNY 64,113,096.18 in the same quarter last year[46] Investment Activities - The company raised CNY 252,200,000.00 from investment activities during the quarter, compared to CNY 2,000,000.00 in the same period last year[50] - Investment activities resulted in a net cash outflow of CNY 164,994,194.91, compared to a net outflow of CNY 16,084,064.50 in the previous year[50] Other Income - The company received government subsidies, contributing to other income of ¥1,980,670.36, marking a 100% increase[16] - The company’s investment income dropped to zero, down 100% from ¥8,233,716.98 in the previous period, due to the absence of gains from the disposal of a subsidiary[16]
艾德生物(300685) - 2017 Q3 - 季度财报